KYLYS AESTHETICS offers a biocompatible hyaluronan-based and thermosensitive dermal filler that has the ability to form microgel structures in the tissue, resulting in a long-lasting effect and no migration from the injection site. Our patented technology allows for injection with an ultra-thin 34G needle, 80% thinner than those used by market alternative, resulting in greater precision, less pain for the patient, and fewer hematomas. With our cutting-edge technology and commitment to research and development, we aim to revolutionize the market of skin filling.
We recently completed all preclinical testing, including biocompatibility, and are now preparing for our 1st pilot clinical trial.
23.06.2025
KYLYS Aesthetics secures CHF 1 M to advance next-gen hyaluronic acid medical devices (venturelab.swiss)
23.06.2025
CHF 1 million to advance KYLYS next-gen hyaluronic acid medical devices (startupticker.ch)
21.05.2024
Venture Leaders Biotech scale new heights in Boston (venturelab.swiss)
06.05.2024
KYLYS AESTHETICS: The Venture Leader Biotech revolutionizing skin filling science (venturelab.swiss)
23.04.2024
The road to Boston: Venture Leaders Biotech 2024 kick-off their roadshow at Swiss Biotech Day (venturelab.swiss)
01.03.2024
Biocompatibility testing
01.11.2023
Start of stability testing
31.07.2023
GMP production
No Jobs
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.kylysaesthetics.com/
Headquarter:
Plan-les-Ouates
Foundation Date:
April 2023
Technology:
Sectors: